STOCK ALARM
PRO
SA
PRO
Discover
Screener
Alerts
News
Portfolio
⌘
K
⌘
J
Pro
Sign In
Free Account
Themes
Merck & Co., Inc.
MRK
NYSE
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Income
Balance
Cash Flow
Annual
Quarterly
3Y
5Y
10Y
All
Revenue
$65B
↑1%
Gross Profit
$53B
↑8%
Operating Income
$27B
↑32%
Net Income
$18B
↑7%
EBITDA
$25B
↓1%
EPS Diluted
7.3
Cost of Revenue
$12B
Gross Margin %
81.5%
R&D Expenses
$16B
SG&A Expenses
$11B
Operating Expenses
$26B
Operating Margin %
41.2%
Interest Expense
$0
Income Before Tax
$21B
Income Tax Expense
$3B
Net Margin %
28.1%
EPS
7.3
Shares Out (Diluted)
2.5B
Shares Out (Basic)
2.5B
Total Costs & Expenses
$38B
Interest Income
$1B
EBITDA Margin %
39.0%
Pre-Tax Margin %
32.4%
Other Income/Expenses
$-6B
Revenue CAGR (5Y)
+9.4%
Margin Trend
improving
Free Cash Flow
Turned negative
Profitability
Profitable
Metric
Dec 21
Dec 22
Dec 23
Dec 24
Dec 25
Revenue
48,704
59,283
↑21.7%
60,115
↑1.4%
64,168
↑6.7%
65,011
↑1.3%
Gross Profit
35,078
41,872
↑19.4%
43,989
↑5.1%
48,975
↑11.3%
52,984
↑8.2%
Operating Income
13,199
18,282
↑38.5%
2,954
↓83.8%
20,221
↑584.5%
26,779
↑32.4%
Net Income
13,049
14,519
↑11.3%
365
↓97.5%
17,117
↑4589.6%
18,254
↑6.6%
EBITDA
17,899
21,315
↑19.1%
6,907
↓67.6%
25,706
↑272.2%
25,360
↓1.3%
EPS Diluted
5.14
5.71
↑11.1%
0.14
↓97.5%
6.74
↑4714.3%
7.28
↑8.0%
Show all metrics
← Newer
1 / 2
Older →
Values in millions except EPS · Ratios shown as percentages